1. Home
  2. SRTA vs VNDA Comparison

SRTA vs VNDA Comparison

Compare SRTA & VNDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

SRTA

Strata Critical Medical Inc.

N/A

Current Price

$4.43

Market Cap

388.1M

Sector

N/A

ML Signal

N/A

Logo Vanda Pharmaceuticals Inc.

VNDA

Vanda Pharmaceuticals Inc.

HOLD

Current Price

$7.33

Market Cap

474.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SRTA
VNDA
Founded
2014
2002
Country
United States
United States
Employees
601
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
388.1M
474.0M
IPO Year
N/A
2005

Fundamental Metrics

Financial Performance
Metric
SRTA
VNDA
Price
$4.43
$7.33
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
5
Target Price
$7.81
$14.90
AVG Volume (30 Days)
649.7K
1.5M
Earning Date
05-15-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$216,105,000.00
Revenue This Year
$39.27
$21.35
Revenue Next Year
$9.09
$37.40
P/E Ratio
$9.88
N/A
Revenue Growth
N/A
8.72
52 Week Low
$3.85
$3.81
52 Week High
$6.02
$9.91

Technical Indicators

Market Signals
Indicator
SRTA
VNDA
Relative Strength Index (RSI) 54.78 47.83
Support Level $4.23 $7.12
Resistance Level $4.69 $7.79
Average True Range (ATR) 0.16 0.32
MACD 0.04 0.03
Stochastic Oscillator 91.40 61.07

Price Performance

Historical Comparison
SRTA
VNDA

About SRTA Strata Critical Medical Inc.

Strata Critical Medical Inc is a time-critical logistics and medical services provider to the U.S. healthcare industry. The group operates one of the nation's air transport and surgical services networks for transplant hospitals and organ procurement organizations, offering an integrated 'One Call' solution for donor organ recovery. It includes two segments: Logistics segments which hold, Air Logistics, Ground Logistics and Organ Placement. The second segment is Clinical Segment which includes: Organ Recovery, Normothermic Regional Perfusion (NRP), and Preservation, and Other Clinical Segment which has Cardiac Care, and Other.

About VNDA Vanda Pharmaceuticals Inc.

Vanda Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of therapies to address high unmet medical needs and improve the lives of patients. Its commercial portfolio comprises three products; HETLIOZ for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24) & nighttime sleep disturbances in Smith-Magenis Syndrome (SMS); Fanapt for the treatment of schizophrenia; and PONVORY. Its other products include VHX-896, ASO Molecules, VQW-765, Tradipitant, VTR-297 and VHX-896. The majority of revenue is derived from the Fanapt product sales. Geographically, the company sells its product predominantly in the United States, and also in Israel, Europe, and Canada.

Share on Social Networks: